S&P 500

5.352,96

-0,02%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
AMEX
Manhattan Pharmaceuticals (MHA)
Manhattan Pharmaceuticals (MHA) Notícias

MHA

Manhattan Pharmaceuticals (MHA)

Manhattan Pharmaceuticals

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:AMEX:MHA

1

Data	Hora	Fonte	Título	Código	Companhia
19/03/2008	13:35	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc-Amended Nat'nl Sec. Exchg. Report the Removal from listing & reg. of matured, redeemed/re.. (25/A)	AMEX:MHA	Manhattan Pharmaceuticals
10/03/2008	15:14	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc-Nat'nl Sec. Exchg. Report the Removal from listing & reg. of matured, redeemed/retired sec. (25)	AMEX:MHA	Manhattan Pharmaceuticals
05/03/2008	18:19	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D)	AMEX:MHA	Manhattan Pharmaceuticals
28/02/2008	16:43	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc - Current report filing (8-K)	AMEX:MHA	Manhattan Pharmaceuticals
13/02/2008	20:12	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)	AMEX:MHA	Manhattan Pharmaceuticals
10/12/2007	10:07	Business Wire	AMEX Accepts Manhattan Pharmaceuticals' Plan to Regain Compliance with Continued Listing Standards	AMEX:MHA	Manhattan Pharmaceuticals
14/11/2007	13:00	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc - Quarterly Report (10-Q)	AMEX:MHA	Manhattan Pharmaceuticals
21/09/2007	15:35	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc (Other) (8-K)	AMEX:MHA	Manhattan Pharmaceuticals
10/07/2007	08:00	PR Newswire (US)	Manhattan Pharmaceuticals Provides Update on Clinical Pipeline	AMEX:MHA	Manhattan Pharmaceuticals
09/07/2007	17:30	PR Newswire (US)	Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone	AMEX:MHA	Manhattan Pharmaceuticals
27/06/2007	09:59	PR Newswire (US)	Manhattan Pharmaceuticals Acquires Hedrin(TM) for the Treatment of Head Lice	AMEX:MHA	Manhattan Pharmaceuticals
10/05/2007	10:29	PR Newswire (US)	Manhattan Pharmaceuticals Successfully Completes Dosing Portion of Two Phase 2a Clinical Trials of Oral Oleoyl-estrone for Obesi	AMEX:MHA	Manhattan Pharmaceuticals
04/04/2007	10:29	PR Newswire (US)	Manhattan Pharmaceuticals Announces License Agreement and Expanded Pipeline	AMEX:MHA	Manhattan Pharmaceuticals
02/04/2007	10:29	PR Newswire (US)	Manhattan Pharmaceuticals Completes $8.6 Million Private Placement	AMEX:MHA	Manhattan Pharmaceuticals
27/03/2007	10:29	PR Newswire (US)	AMEX Accepts Manhattan Pharmaceuticals' Plan to Regain Compliance With Continued Listing Standards	AMEX:MHA	Manhattan Pharmaceuticals
21/02/2007	11:29	PR Newswire (US)	Manhattan Pharmaceuticals Completes Enrollment in Phase 2a Study of Oral Oleoyl-estrone for Obesity	AMEX:MHA	Manhattan Pharmaceuticals
08/11/2006	11:29	PR Newswire (US)	Manhattan Pharmaceuticals Expands Phase 2a Obesity Clinical Trial Sites to US	AMEX:MHA	Manhattan Pharmaceuticals
12/10/2006	10:29	PR Newswire (US)	Manhattan Pharmaceuticals Expanding Oral Oleoyl-estrone Clinical Program to Include Morbidly Obese	AMEX:MHA	Manhattan Pharmaceuticals
29/06/2006	12:29	PR Newswire (US)	Manhattan Pharmaceuticals Doses First Patient Group In Phase IIa Trial For OE, Its Oral Obesity Drug Candidate	AMEX:MHA	Manhattan Pharmaceuticals
16/05/2006	10:02	PR Newswire (US)	Manhattan Pharmaceuticals Receives SwissMedic's Approval to Commence Phase IIa Trial With OE, Its Oral Obesity Drug Candidate	AMEX:MHA	Manhattan Pharmaceuticals
28/12/2005	14:25	PR Newswire (US)	Manhattan Pharmaceuticals' Topical Psoriasis Treatment in Phase IIa Trial	AMEX:MHA	Manhattan Pharmaceuticals
07/10/2005	14:35	PR Newswire (US)	American Stock Exchange Lists Common Stock of Manhattan Pharmaceutical Inc.	AMEX:MHA